Densely Ionizing Radiation Acts via the Microenvironment to Promote Aggressive Trp53 -Null Mammary Carcinomas
Published version of a preprint
Abstract
Densely ionizing radiation, which is present in the space radiation environment and used in radiation oncology, has potentially greater carcinogenic effect compared with sparsely ionizing radiation that is prevalent on earth. Here, we used a radiation chimera in which mice were exposed to densely ionizing 350 MeV/amu Si-particles, γ-radiation, or sham-irradiated and transplanted 3 days later with syngeneic Trp53-null mammary fragments. Trp53-null tumors arising in mice irradiated with Si-particles had a shorter median time to appearance and grew faster once detected compared with those in sham-irradiated or γ-irradiated mice. Tumors were further classified by markers keratin 8/18 (K18, KRT18), keratin 14 (K14, KRT14) and estrogen receptor (ER, ESR1), and expression profiling. Most tumors arising in sham-irradiated hosts were comprised of both K18- and K14-positive cells (K14/18) while those tumors arising in irradiated hosts were mostly K18. Keratin staining was significantly associated with ER status: K14/18 tumors were predominantly ER-positive, whereas K18 tumors were predominantly ER-negative. Genes differentially expressed in K18 tumors compared with K14/18 tumor were associated with ERBB2 and KRAS, metastasis, and loss of E-cadherin. Consistent with this, K18 tumors tended to grow faster and be more metastatic than K14/18 tumors, however, K18 tumors in particle-irradiated mice grew significantly larger and were more metastatic compared with sham-irradiated mice. An expr…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In mammary tumors, differences in tumor types comparing heavy ions to low LET radiation were observed, with more aggressive tumors observed.
“Mammary tumors (Illa-Bochaca et al., 2014;Omene et al., 2020;Imaoka et al., 2007) Differences in mammary tumor types comparing heavy ions to low LET radiation with more aggressive tumors observed.”
From A proposed change to astronaut exposures limits is a giant leap backwards for radiation protection (2021) · cites this paper as Illa-Bochaca et al., 2014
NTEs have been shown to impact initiation, promotion and progression stages of tumorigenesis at low doses of high LET radiation.
“NTE have been shown to impact initiation, promotion and progression stages of tumorigenesis at low doses of high LET radiation (Illa-Bochaca et al., 2014;Omene et al., 2020;Maxwell et al., 2008;Kadhim et al., 2013;Lorimore et al., 2003;Barcellos-Hoff and Mao, 2016;Hada et al., 2014;Nagasawa and Little, 1992;Belyakov et al., 2005;Chang et al., 2016).”
From A proposed change to astronaut exposures limits is a giant leap backwards for radiation protection (2021) · cites this paper as Illa-Bochaca et al., 2014
Cites
Heavy ion carcinogenesis and human space exploration
Durante, M., & Cucinotta, F. A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2391 · Cited by 578 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
A New Approach to Reduce Uncertainties in Space Radiation Cancer Risk Predictions
Cucinotta, F. A. (2015) · PLOS ONE · doi:10.1371/journal.pone.0120717 · Cited by 79 · see citing works
A proposed change to astronaut exposures limits is a giant leap backwards for radiation protection
Cucinotta, F. A., Schimmerling, W., Blakely, E. A., & Hei, T. K. (2021) · Life Sciences in Space Research · doi:10.1016/j.lssr.2021.07.005 · Cited by 35 · see citing works
- Authors
- Illa-Bochaca, I., Ouyang, H., Tang, J., Sebastiano, C., Mao, J.-H., Costes, S. V., Demaria, S., & Barcellos-Hoff, M. H.
- Affiliations
- New York University (US)
- Lawrence Berkeley National Laboratory (US)
- 1Department of Radiation Oncology, New York University School of Medicine, New York, New York.
- Venue
- Cancer Research
- Published
- 2014-11-30
- Volume
- 74
- Issue
- 23
- Pages
- 7137-7148
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2116184323
- Cited by
- 29
- References
- 1
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 3 · 2022: 5 · 2021: 6 · 2020: 3 · 2019: 2 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 3
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Radiation Therapy and Dosimetry
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- high-LET radiation, radiation-induced cancer, tumor microenvironment, syngeneic tumor transplantation, cytokeratin 18, keratin 14, estrogen receptor status, metastasis, ERBB2, KRAS, E-cadherin loss, mammary stem cells, Notch signaling, gene expression profiling, radiation chimeras
- MeSH terms
- Animals, Female, Keratins, Mammary Neoplasms, Experimental, Mice, Inbred BALB C, Radiation, Ionizing, Receptors, Estrogen, Stem Cells, Biomarkers, Tumor, Cadherins, Tumor Suppressor Protein p53, Proto-Oncogene Proteins p21(ras), Receptor, ErbB-2, Erb-b2 Receptor Tyrosine Kinases, Gene Expression Profiling, Mice, Receptors, Notch, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review